CO4990960A1 - Derivados de cetolidos 2-halo-6-o sustituidos - Google Patents

Derivados de cetolidos 2-halo-6-o sustituidos

Info

Publication number
CO4990960A1
CO4990960A1 CO98062730A CO98062730A CO4990960A1 CO 4990960 A1 CO4990960 A1 CO 4990960A1 CO 98062730 A CO98062730 A CO 98062730A CO 98062730 A CO98062730 A CO 98062730A CO 4990960 A1 CO4990960 A1 CO 4990960A1
Authority
CO
Colombia
Prior art keywords
group
aryl
substituted
heteroaryl
alkyl
Prior art date
Application number
CO98062730A
Other languages
English (en)
Inventor
T Phan Ly
Jacob J Plattner
Yat Sun Or
Chen Yan
Daniel T Chu
Richard F Vlark
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CO4990960A1 publication Critical patent/CO4990960A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Un compuesto seleccionado del grupo conformado por: y las sales ó ésteres farmacéuticamente aceptables de estos, en donde RP es hidrógeno o un grupo protector de hidroxi; X es F, Cl, Br, o I; y R1 se selecciona del grupo conformado por (1) alquil C1 C6 opcionalmente sustituido con uno o más sustituyentes seleccionados del grupo conformado por (a) aril, (b) aril substituido a través del reemplazo independiente de uno, dos o tres átomos de hidrógeno de dichos grupos con Cl, Br, F, I, OH, CN, alquil C1 -C3 , alcoxi C1 -C6 , alcoxi C1 -C6 substituido con aril, haloalquil, tioalcoxi, amino, alquilamino, dialquilamino, mercapto, nitro, carboxaldehído, carboxi, alcoxicarbonil y carboxamida. Por otra parte, uno cualquiera de los substituyentes puede tratarse de un grupo aril, heteroaril, ó heterocicloalquil (c) heteroaril, (d) heteroaril sustituido a través del reemplazo independiente de uno, dos o tres átomos de hidrógeno de dicho grupo con Cl, Br, F, I, OH, CN, alquil C1 -C3 , alcoxi C1 -C6 , alcoxi C1 -C6 substituido con aril, haloalquil, tioalcoxi, amino, alquilamino, dialquilamino, mercapto, nitro, carboxaldehído, carboxi, alcoxicarbonil, carboxamida, amino N-protegido, -CH(=N-OH), -CH(=N-NH2 ), y -CH(=N-N=C(CH3 )2 )). Además uno cualquiera de los substituyentes puede tratarse de un grupo aril, heteroaril, o uno heterocicloalquil. (e) -NR3 R4 en donde R3 y R4 se seleccionan independientemente entre hidrógeno y alquil C1 -C3 , ó R3 y R4 tomados junto con el átomo al cual van ligados forman un anillo de 3 a 7 miembros que contiene una porción molecular ...
CO98062730A 1997-10-29 1998-10-27 Derivados de cetolidos 2-halo-6-o sustituidos CO4990960A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95988197A 1997-10-29 1997-10-29
US15423998A 1998-09-16 1998-09-16

Publications (1)

Publication Number Publication Date
CO4990960A1 true CO4990960A1 (es) 2000-12-26

Family

ID=26851273

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98062730A CO4990960A1 (es) 1997-10-29 1998-10-27 Derivados de cetolidos 2-halo-6-o sustituidos

Country Status (25)

Country Link
EP (1) EP1027362B1 (es)
JP (1) JP2001521039A (es)
KR (1) KR100536420B1 (es)
CN (1) CN1240707C (es)
AR (1) AR015994A1 (es)
AT (1) ATE298760T1 (es)
AU (1) AU751448B2 (es)
BG (1) BG64707B1 (es)
BR (1) BR9813319A (es)
CA (1) CA2307788C (es)
CO (1) CO4990960A1 (es)
CZ (1) CZ300063B6 (es)
DE (1) DE69830739T2 (es)
DK (1) DK1027362T3 (es)
ES (1) ES2244094T3 (es)
HK (1) HK1031383A1 (es)
HU (1) HUP0004282A3 (es)
IL (1) IL135519A0 (es)
NO (1) NO20002190L (es)
NZ (1) NZ503822A (es)
PL (1) PL191453B1 (es)
PT (1) PT1027362E (es)
SK (1) SK286397B6 (es)
TR (1) TR200001142T2 (es)
WO (1) WO1999021871A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39743E1 (en) * 1998-10-15 2007-07-24 Aventis Pharma S.A. 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
FR2784682B1 (fr) 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
KR100710605B1 (ko) 1999-04-16 2007-04-24 코산 바이오사이언시즈, 인코포레이티드 매크롤라이드 항감염제
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
ES2306674T3 (es) * 1999-12-02 2008-11-16 Abbott Laboratories Derivados cetolidos 6-o-alquil-2-nor-2-sustituidos.
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
JP2001261694A (ja) 2000-03-06 2001-09-26 Pfizer Prod Inc ケトライド抗生物質
US6605707B1 (en) 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
US6713455B2 (en) 2001-09-17 2004-03-30 Ortho-Mcneil Pharmaceutical, Inc. 6-O-carbamate-11,12-lacto-ketolide antimicrobials
HUP0500018A3 (en) 2001-12-05 2009-09-28 Ortho Mcneil Pharm Inc 6-o-acyl ketolide derivatives of erythromycine processes for preparing them and using them as antibacterials
JP2005522453A (ja) * 2002-02-13 2005-07-28 アボット・ラボラトリーズ マクロライド抗菌化合物
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
JP2005528409A (ja) * 2002-04-25 2005-09-22 アボット・ラボラトリーズ オキソリド抗菌薬
WO2004078771A1 (ja) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. 2-フルオロ-6-o-置換ケトライド誘導体
JP2007254285A (ja) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd 2−フルオロ−6−o−置換ケトライド誘導体
CN102459296B (zh) * 2009-05-27 2014-10-29 沃克哈特研究中心 具有抗微生物活性的酮内酯类化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5591837A (en) * 1992-04-22 1997-01-07 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide a derivative
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
TR200001142T2 (tr) 2000-09-21
BG104434A (en) 2001-01-31
KR100536420B1 (ko) 2005-12-16
AR015994A1 (es) 2001-05-30
HK1031383A1 (en) 2001-06-15
WO1999021871A1 (en) 1999-05-06
JP2001521039A (ja) 2001-11-06
NZ503822A (en) 2002-12-20
AU1288199A (en) 1999-05-17
BR9813319A (pt) 2000-08-22
EP1027362B1 (en) 2005-06-29
DE69830739T2 (de) 2006-04-20
BG64707B1 (bg) 2005-12-30
PT1027362E (pt) 2005-08-31
SK6332000A3 (en) 2000-09-12
ES2244094T3 (es) 2005-12-01
ATE298760T1 (de) 2005-07-15
CA2307788C (en) 2008-05-20
CN1283199A (zh) 2001-02-07
EP1027362A1 (en) 2000-08-16
CZ300063B6 (cs) 2009-01-21
SK286397B6 (sk) 2008-09-05
DK1027362T3 (da) 2005-10-31
HUP0004282A3 (en) 2001-10-29
IL135519A0 (en) 2001-05-20
NO20002190D0 (no) 2000-04-27
CZ20001525A3 (cs) 2000-10-11
PL340290A1 (en) 2001-01-29
DE69830739D1 (de) 2005-08-04
NO20002190L (no) 2000-06-29
AU751448B2 (en) 2002-08-15
CA2307788A1 (en) 1999-05-06
HUP0004282A2 (hu) 2001-04-28
CN1240707C (zh) 2006-02-08
KR20010015793A (ko) 2001-02-26
PL191453B1 (pl) 2006-05-31

Similar Documents

Publication Publication Date Title
CO4990960A1 (es) Derivados de cetolidos 2-halo-6-o sustituidos
CA2423103A1 (en) N-acylsulfonamide apoptosis promoters
DOP2006000063A (es) Derivados de ciclopropanocarboxamida
CO5251440A1 (es) Derivados de heterociclil-fenil-oxazolidin-tiofencarboxamida, su procedimiento de obtencion y medicamentos que los contienen
HUP0001269A2 (hu) 2-Oxo-1-azetidin-szulfonsav-származékok és ezeket tartalmazó kombinált gyógyszerkészítmények
CO5650253A2 (es) Piperazina con grupo fenilo or-sustituido y su uso como inhibidores de glyt1
AR012315A1 (es) Derivados de ditiolan y el uso de los mismos en la fabricacion de un medicamento.
CO5200848A1 (es) Derivados de 3(5)-ureido-pirazol, proceso para su prepa- racion y su utilizacion como agentes antitumorales
CA2475432A1 (en) 2,4,6-triamino-1,3,5-triazine derivative
NO931433L (no) 4,1-benzoksazepinderivater og deres anvendelse
MX9307052A (es) Derivados del taxano sustituidos con furil-carbonilo o tienil-carbonilo y composiciones farmaceuticas que los contienen.
NO20013379D0 (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
HUP0402313A2 (hu) Szerotonin újrafelvételt gátló fenilpiperazin-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
HUP0201935A2 (hu) A SYK tirozin-protein-kináz inhibitoraiként alkalmazható purinszármazékok
CO5721006A2 (es) Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa
DK0624584T3 (da) Piperazinderivater, der er nyttige som calmodulininhibitorer
PE20050652A1 (es) Mezclas que contienen estrobilurinas y moduladores de etileno
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
ES2188194T3 (es) 1,8-naftiridin-4(1h)-onas sustituidas como inhibidores de la fosfodiesterasa 4.
AR020165A1 (es) Derivados de pirimidinas sustituidas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y el uso de los mismos para la preparacion de medicamentos
CA2188690A1 (en) Selective thrombin inhibitors
CO5271742A1 (es) Macrolidos 6-0 substituidos que tienen actividad antibacteriana
NZ214787A (en) Arylcyclobutylalkylamines and pharmaceutical compositions
HUP0002848A2 (hu) Ciklobuténszármazékok, eljárás előállításukra és terápiás alkalmazásuk
HUP0301478A2 (hu) Antibakteriális aktivitású pleuromutilinszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk